Video

Workplace Wellness Can Help Reduce the Risk for Heart Problems

Some Parents May Hasten Death for Terminally Ill Children

Fitness Academics

Secondhand Smoke Increases Risk for Heart Disease in Kids

Toddlers Don't Learn Vocabulary From TV

Despite Worries, Most Parents Vaccinate Their Kids Anyway

Food Allergies Can Be Treated With the Allergen Foods

Signs of Heart Disease Could Be As Early as 3 in Obese Kids

The Number of Women Having Strokes is Rising

Preventative Mastectomy

Cases of Gestational Diabetes Are On the Rise

Nintendo Wii Could Be Therapy for Stroke Victims

Single Men Have An Increased Risk for Stroke

Fatty Foods Could Lead to Stroke in Older Women

Woman Gives Birth After Ovary Transplant

Protein May Hold Key to Blocking Allergy-Induced Asthma

Posted on 05/21/2009, 16:00
By -- Robert Preidt

Team finds mice lacking certain gene showed fewer signs of condition

THURSDAY, May 21 (HealthDay News) -- A protein that might be linked to allergy-induced asthma has been identified by U.S. researchers, who said their finding could lead to new drugs to treat the disease.

The researchers found that mice without the ion channel protein TRPA1 showed fewer signs of asthma.

"When compared to normal mice, those lacking the gene for TRPA1 had greatly diminished inflammation, airway mucus and bronchoconstriction," the study's lead author, Sven-Eric Jordt, an assistant professor of pharmacology at Yale School of Medicine, said in a Yale news release.

Previous research has shown that TRPA1 is a sensor for irritants such as cigarette smoke and certain chemicals that can trigger asthma. The protein is found in airway nerve cells that control pain and irritation and trigger coughing and sneezing.

The researchers also found that a drug called HC-030031 -- which is known to inhibit pain related to TRPA1 -- reduced asthma symptoms in mice.

"Blocking TRPA1 may prevent the infiltration of the lung by the inflammatory cells responsible for asthma symptoms such as wheezing and mucus overproduction," Jordt said.

Several of the researchers are advisers or employees of the biosciences company that is developing HC-030031 as a potential asthma drug.

The study appears online in the journal Proceedings of the National Academy of Sciences.

More information

The U.S. National Heart, Lung and Blood Institute has more about asthma.

SOURCE: Yale University, news release, May 18, 2009

More news in Allergy...

BigHealthTree.com Disclaimer

Bighealthtree.com Does Not Provide Medical Advice. This site, including the above information, is for informational purposes only and is not a substitute for professional medical or health advice. Always seek the advice of your physician or a qualified health or medical professional before starting any new treatment, changing existing treatment, or altering your current exercise and/or diet program. If you think you are having a medical emergency, call 911 (or the emergency services in your area) or your doctor immediately.

Rating: 2.7 / 5 (29 votes)